bisbenzimidazole has been researched along with Ascites in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roopashree, R | 1 |
| Mohan, CD | 1 |
| Swaroop, TR | 1 |
| Jagadish, S | 1 |
| Raghava, B | 1 |
| Balaji, KS | 1 |
| Jayarama, S | 1 |
| Rangappa, KS | 1 |
1 other study available for bisbenzimidazole and Ascites
| Article | Year |
|---|---|
Novel synthetic bisbenzimidazole that targets angiogenesis in Ehrlich ascites carcinoma bearing mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Ascites; Bisbenzimidazole; Body Weight; Car | 2015 |